Dallas, Texas (PRWEB) September 28, 2012
Expanding population, improved access to healthcare, and the burgeoning middle class are key growth drivers for Brazil Pharmaceutical Market that is increasingly opting for branded drugs. Consequently, Big Pharma is targeting Brazil to offset slowing sales growth in more developed markets.
Features and benefits:
- Analysis of population demographics, economic wealth, disease burden, level of industrialization, and political structure in Brazil.
- Insight into the healthcare system, drug regulation, drug pricing, drug reimbursement, and intellectual property position in Brazil.
- Assesses the generics and biosimilars landscape in terms of regulatory issues, level of penetration, and key players in Brazil.
- Overview of key market segment sales and top companies, and R&D and manufacturing infrastructure for the leading pharmaceutical companies in Brazil.
Identifying opportunities in local health market economies requires detailed knowledge of the economic performance and health infrastructure at a city/provincial/regional level. Being able to see that in the context of the neighbouring districts/regions as well as the national picture, brings focus to areas of opportunity and need. This report helps you drill down into local and regional health markets in Brazil, Russia, India and China to better understand the opportunities and challenges and get answers to questions like:
- How is the population and wealth distributed?
- Which states and territories produce the highest levels of GDP?
- What is the primary and secondary health infrastructure in each region?
- How is healthcare delivered?
- What is the role played by private/government health provision at state level?
- Which regions are better provided for and which still need investment?
- At 194.7 million, the population of Brazil is the fifth largest in the world. Average population growth is around 1.1% per annum. Around 21.6% of the population reside in São Paulo state and 8.4% live in the state of Rio de Janeiro. The 2010 census identified 14.1 million people aged 65 or older, equivalent to 7.4% of the population.
- In 2011, Brazil spent R$368.2 billion (US$219.8 billion) on healthcare, equivalent to 8.8% of GDP. Private spending accounted for 52.7% of the total, more than half of which was out of pocket spending. Public health spending amounted to US$115.8 billion. Per capita health spending was around US$1,140.
- The Russian Federation is the largest country in the world, with a land area of over 17 million square kilometres, encompassing eleven time zones. After the breakup of the USSR, the Russian Federation retained over 75% of the USSR's total land area and 51% of its population.
- The population of Russia was estimated at 142.9 million in 2010, an increase of 0.71% over 2009. Prior to 2010, the growth rate remained negative, decreasing by an average of 0.4% each year since 1999.
- The country is organised into 8 districts which are further subdivided into 82 regions, autonomous areas and republics.
India’s 1.21 billion population is distributed across 35 states and union territories, and is growing at 1.6% per year. In terms of landmass, India is approximately one third the size of the USA.
India has an established mainly urban middle class but the bulk of the population have little by way of income and resources. This is exacerbated in India where, despite there being over 45 cities with more than 1 million inhabitants, the majority of the population live rurally in over 638,000 villages – many of them remote and difficult to access. The impact on key health indicators, such as infant mortality, can be clearly seen and despite per capita health spending more than doubling in the last 10 years there is some way to go.
22 Provinces, 4 Municipalities and 5 Autonomous Regions each with an average population of nearly 42 million, each with differing health provision and needs.
China has been a focus of interest for international business for such a long time now that it has become easy to assess markets and economic performance in national terms. Even the much discussed and fast developing urban areas such as Beijing, Shanghai and Tianjin are representative of only a fraction of the widely diverse regional markets to be found elsewhere in the country.
Contact sales(at)reportsandreports(dot)com for further information.
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of 5000+ micro markets. We provide 24/7 online and offline support service to our customers.